Prescription drugs treat conditions and improve patient health. But when drug prices are too high, access to medicines becomes out of reach for far too many patients.This crisis is fueled by the high launch prices of new brand biologics and year-over-year price increases of brand drugs that face no competition in the market for many years due to abuses of the patent system. Increasing patient access to more affordable, FDA-approved generic and biosimilar medicines is a proven and tested solution to lowering prescription drug costs. When generic competition exists, prices are often 80-85 percent less than the brand drug,3 according to the FDA. It’s time to do something about sky-high prescription drug costs. Let’s increase competition, end patent abuse and work to bring drug prices back down to Earth.
